Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study

Niels H Chavannes1 Department of Public health and Primary Care, Leiden University Medical Center, The Netherlands;2 Caphri Research Institute, Department of General Practice, Maastricht University, The NetherlandsCorrespondence[email protected]

Tjard RJ Schermer3 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands

Emiel FM Wouters4 Department of Pulmonary Diseases, University Hospital Maastricht, The Netherlands

Reinier P Akkermans3 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands

Richard PN Dekhuijzen5 Department of Pulmonary Diseases, Radboud University Nijmegen Medical Center, The Netherlands

Jean WM Muris2 Caphri Research Institute, Department of General Practice, Maastricht University, The Netherlands

Chris Van Weel3 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands

Onno CP Van Schayck2 Caphri Research Institute, Department of General Practice, Maastricht University, The Netherlands

show all

Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study

Table 1 Population characteristics of responders versus nonresponders according to former international guidelines^Citation13^–^Citation15

Table 2 Long-term effectiveness of fluticasone propionate versus placebo in responders and nonresponders on exacerbations, health status, and lung function according to different international guidelines^Citation13^–^Citation15

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study

Figures & data

Table 1 Population characteristics of responders versus nonresponders according to former international guidelinesCitation13–Citation15

Table 2 Long-term effectiveness of fluticasone propionate versus placebo in responders and nonresponders on exacerbations, health status, and lung function according to different international guidelinesCitation13–Citation15

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 1 Population characteristics of responders versus nonresponders according to former international guidelines^Citation13^–^Citation15

Table 2 Long-term effectiveness of fluticasone propionate versus placebo in responders and nonresponders on exacerbations, health status, and lung function according to different international guidelines^Citation13^–^Citation15